A recent study reported by Wang group shows that METTL14 promotes SOX4 mRNA degradation by relying on YTHDF2-dependent pathway, and this can inhibit CRC progression partly through SOX4-mediated EMT process and PI3K/Akt signals [71]. This evidence concerns the gene METTL14 and colorectal carcinoma.